Advanced search
Publication Cover
Postgraduate Medicine Volume 123, 2011 - Issue 5
Submit an article Journal homepage
111
Views
7
CrossRef citations to date
0
Altmetric
Clinical Focus: ADHD, Depression, Pain, and Neurological Disorders

Single-Dose Pharmacokinetics of NWP06, an Extended-Release Methylphenidate Suspension, in Children and Adolescents with ADHD

Ann C. Childress Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
, MD,
F. Randy Sallee Department of Psychiatry, University of Cincinnati, Cincinnati, OH
, MD, PhD &
Sally A. Berry NextWave Pharmaceuticals, Cupertino, CACorrespondence[email protected]
, MD, PhD
Pages 80-88 | Published online: 13 Mar 2015

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ann C. Childress, Marina Komolova & F. Randy Sallee. (2019) An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology 15:11, pages 937-974.
Read now
Ann C. Childress. (2016) Methylphenidate HCL for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy 17:8, pages 1171-1178.
Read now
Ann Childress & Floyd R Sallee. (2013) The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD. Expert Review of Neurotherapeutics 13:9, pages 979-988.
Read now

Articles from other publishers (4)

Andrew J. Cutler & Gregory W. Mattingly. (2017) Beyond the pill: new medication delivery options for ADHD. CNS Spectrums 22:6, pages 463-474.
Crossref
Samuele Cortese, Giulia D’Acunto, Eric Konofal, Gabriele Masi & Benedetto Vitiello. (2017) New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability. CNS Drugs 31:2, pages 149-160.
Crossref
David Sugrue, Robin Bogner & Megan J. Ehret. (2014) Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder. American Journal of Health-System Pharmacy 71:14, pages 1163-1170.
Crossref
Sharon B. WigalAnn C. ChildressHeidi W. BeldenSally A. Berry. (2013) NWP06, an Extended-Release Oral Suspension of Methylphenidate, Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology 23:1, pages 3-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.